推荐产品
化驗
99%
形狀
solid
bp
224 °C (lit.)
mp
38-40 °C (lit.)
溶解度
95% ethanol: soluble 25 mg/mL, clear, colorless to yellow
SMILES 字串
FC(F)(F)C(=O)CC(=O)c1ccccc1
InChI
1S/C10H7F3O2/c11-10(12,13)9(15)6-8(14)7-4-2-1-3-5-7/h1-5H,6H2
InChI 密鑰
VVXLFFIFNVKFBD-UHFFFAOYSA-N
應用
4,4,4-三氟-1-苯基-1,3-丁二酮通过席夫碱缩合反应合成了一系列三氟甲基取代的 NNO 酮亚胺 。它还被用于混合配体螯合萃取三价镧系元素 和作为配体制备三元镧系元素 (Ln) 配合物 。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
210.2 °F - closed cup
閃點（°C）
99 °C - closed cup
其他客户在看
Yosuke Hata et al.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 27(4), 641-646 (2020-06-24)
Purpose: To investigate the prognostic impact of infrapopliteal (IP) artery anatomic severity according to the Global Limb Anatomic Staging System (GLASS) on delayed wound healing in patients with chronic limb-threatening ischemia (CLTI). Materials and Methods: This study retrospectively analyzed 639
Makoto Utsunomiya et al.
JACC. Cardiovascular interventions, 10(2), 188-194 (2017-01-21)
This study aimed to assess the optimal angiographic endpoint of endovascular therapy (EVT) for wound healing. Several reports have demonstrated acceptable patency and limb salvage rates following infrapopliteal interventions for the treatment of critical limb ischemia (CLI). However, the optimal angiographic
Syntheses, crystal structures, visible and near-IR luminescent properties of ternary lanthanide (Dy3+, Tm3+) complexes containing 4, 4, 4-trifluoro-1-phenyl-1, 3-butanedione and 1, 10-phenanthroline.
Feng J, et al.
Journal of Luminescence, 128(12), 1957-1964 (2008)
M E Grobman et al.
Journal of veterinary internal medicine, 33(3), 1423-1433 (2019-04-11)
Megaesophagus (ME) carries a poor long-term prognosis in dogs. In people, lower esophageal sphincter (LES) achalasia is a rare cause of ME that may respond to targeted intervention. Dogs with lower esophageal sphincter achalasia-like syndrome (LES-AS) have been described recently
Jean-Jacques Body et al.
Journal of bone oncology, 14, 100212-100212 (2019-01-11)
Bone metastases (BMs) are common in patients with prostate cancer and can lead to skeletal-related events (SREs), which are associated with increased pain and reduced quality of life (QoL). Bone-targeted agents (BTAs), such as zoledronic acid and denosumab, reduce the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门